iLoF is a series a startup based in United Kingdom. 1 investor tracked.
Based in the United Kingdom, iLoF is a startup founded in 2020. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
iLoF is an AI-powered platform that uses photonics to create 'digital fingerprints' of biological samples. This technology accelerates drug discovery and development, particularly for neurodegenerative diseases like Alzheimer's, by enabling patient stratification for clinical trials.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.